PL3325080T3 - Sposoby lepszego dostarczania środków czynnych do guzów - Google Patents

Sposoby lepszego dostarczania środków czynnych do guzów

Info

Publication number
PL3325080T3
PL3325080T3 PL16831139T PL16831139T PL3325080T3 PL 3325080 T3 PL3325080 T3 PL 3325080T3 PL 16831139 T PL16831139 T PL 16831139T PL 16831139 T PL16831139 T PL 16831139T PL 3325080 T3 PL3325080 T3 PL 3325080T3
Authority
PL
Poland
Prior art keywords
tumors
ways
active agents
better delivery
delivery
Prior art date
Application number
PL16831139T
Other languages
English (en)
Inventor
Russell Frederick Ross
Original Assignee
Sorrento Therapeutics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sorrento Therapeutics, Inc. filed Critical Sorrento Therapeutics, Inc.
Publication of PL3325080T3 publication Critical patent/PL3325080T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays or needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M2037/0007—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0023—Drug applicators using microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0038—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles having a channel at the side surface
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0061—Methods for using microneedles

Landscapes

  • Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Medical Informatics (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
PL16831139T 2015-07-24 2016-07-22 Sposoby lepszego dostarczania środków czynnych do guzów PL3325080T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201562196570P 2015-07-24 2015-07-24
US201562196578P 2015-07-24 2015-07-24
PCT/US2016/043623 WO2017019526A2 (en) 2015-07-24 2016-07-22 Methods for better delivery of active agents to tumors
EP16831139.7A EP3325080B1 (en) 2015-07-24 2016-07-22 Methods for better delivery of active agents to tumors

Publications (1)

Publication Number Publication Date
PL3325080T3 true PL3325080T3 (pl) 2022-01-24

Family

ID=57885141

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16831139T PL3325080T3 (pl) 2015-07-24 2016-07-22 Sposoby lepszego dostarczania środków czynnych do guzów

Country Status (15)

Country Link
US (3) US10806913B2 (pl)
EP (2) EP3925599A1 (pl)
JP (1) JP7082041B2 (pl)
KR (1) KR20180035209A (pl)
CN (2) CN118902979A (pl)
AU (3) AU2016297823B2 (pl)
BR (1) BR112018001292A2 (pl)
CA (1) CA2991455C (pl)
DK (1) DK3325080T3 (pl)
ES (1) ES2891523T3 (pl)
HU (1) HUE056410T2 (pl)
MX (2) MX2018000166A (pl)
PL (1) PL3325080T3 (pl)
RU (1) RU2719943C2 (pl)
WO (1) WO2017019526A2 (pl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3325081T3 (pl) * 2015-07-24 2021-12-20 Sorrento Therapeutics, Inc. Sposoby dostarczania limfatycznego środków czynnych
EP3925599A1 (en) * 2015-07-24 2021-12-22 Sorrento Therapeutics, Inc. Methods for better delivery of active agents to tumors
US11207272B2 (en) 2017-05-17 2021-12-28 Massachusetts Institute Of Technology Tissue anchoring articles
US11541015B2 (en) 2017-05-17 2023-01-03 Massachusetts Institute Of Technology Self-righting systems, methods, and related components
US11659837B2 (en) 2017-07-10 2023-05-30 Basf Se Mixtures comprising an urease inhibitor (UI) and a nitrification inhibitor such as 2-(3,4-dimethyl-1H-pyrazol-1-yl)succinic acid (DMPSA) or 3,4-dimethyl pyrazolium glycolate (DMPG)
AU2019269636A1 (en) 2018-05-17 2020-11-19 Massachusetts Institute Of Technology Systems for electrical stimulation
JP2021525576A (ja) * 2018-05-31 2021-09-27 ソレント・セラピューティクス・インコーポレイテッドＳｏｒｒｅｎｔｏ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． リンパ系を標的化した薬物送達方法
WO2020064083A1 (en) 2018-09-24 2020-04-02 L'oreal Device comprising microneedles for in-situ reaction of a skin
EP3856321A1 (en) * 2018-09-24 2021-08-04 L'oreal Device comprising microneedles for skin-coloring
WO2021113585A1 (en) 2019-12-05 2021-06-10 Sorrento Therapeutics, Inc. Method of treating cancer by administration of an anti-pd-1 or anti-pd-l1 therapeutic agent via a lymphatic delivery device
CN117813128A (zh) 2021-01-22 2024-04-02 索伦托药业有限公司 用于微升级淋巴递送冠状病毒疫苗的装置
WO2022192594A2 (en) 2021-03-11 2022-09-15 Sorrento Therapeutics, Inc. Nucleic acid molecules and vaccines comprising same for the prevention and treatment of coronavirus infections and disease
WO2022261262A1 (en) 2021-06-09 2022-12-15 Sorrento Therapeutics, Inc. Method of treating cancer by administration of an anti-pd-1 or anti-pd-l1 therapeutic agent via a lymphatic microneedle delivery device
US20250120905A1 (en) 2021-08-18 2025-04-17 Vivasor, Inc Therapeutic agents targeting the lymphatic system
WO2025129128A1 (en) 2023-12-15 2025-06-19 Vivasor, Inc. Compositions and methods for non-viral delivery of therapeutic compounds

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE72524B1 (en) 1994-11-04 1997-04-23 Elan Med Tech Analyte-controlled liquid delivery device and analyte monitor
NZ516582A (en) 2000-06-01 2004-08-27 Watson Pharmaceuticals Inc Transdermal delivery of lasofoxifene
WO2003022330A2 (en) * 2001-09-12 2003-03-20 Becton, Dickinson And Company Microneedle-based pen device for drug delivery and method for using same
JP2007500251A (ja) * 2003-06-13 2007-01-11 ベクトン・ディキンソン・アンド・カンパニー 生物学的に活性な作用物質の改良型皮内送達
US20050180952A1 (en) 2003-08-26 2005-08-18 Pettis Ronald J. Methods for intradermal delivery of therapeutics agents
AU2005284908B2 (en) * 2004-09-13 2011-12-08 Morningside Venture Investments Limited Biosynchronous transdermal drug delivery
WO2006127962A2 (en) * 2005-05-25 2006-11-30 Becton, Dickinson And Comapny Particulate formulations for intradermal delivery of biologically active agents
WO2006138719A2 (en) * 2005-06-17 2006-12-28 Georgia Tech Research Corporation Coated microstructures and method of manufacture thereof
US8197435B2 (en) * 2006-05-02 2012-06-12 Emory University Methods and devices for drug delivery to ocular tissue using microneedle
EP2100850A1 (en) * 2008-03-11 2009-09-16 Stichting Voor De Technische Wetenschappen Microneedle array and a method for manufacturing microneedles
US8715736B2 (en) * 2009-04-30 2014-05-06 Florida Agricultural And Mechanical University Nanoparticle formulations for skin delivery
CN101829394B (zh) * 2010-04-27 2012-08-22 上海交通大学 台阶微针阵列的制备方法
CN102985131B (zh) 2010-04-28 2016-06-29 金伯利-克拉克环球有限公司 用于递送siRNA的医疗装置
CA2797204C (en) 2010-04-28 2018-06-12 Kimberly-Clark Worldwide, Inc. Device for delivery of rheumatoid arthritis medication
AU2011311255B2 (en) 2010-04-28 2015-10-08 Sorrento Therapeutics, Inc. Method for increasing permeability of an epithelial barrier
RU2570280C2 (ru) 2010-04-28 2015-12-10 Кимберли-Кларк Ворлдвайд, Инк. Композитная матрица микроигл, содержащая на поверхности наноструктуры
US20120187814A1 (en) 2011-01-25 2012-07-26 Fryling Nicholas A Furniture System and a Frame Assembly for a Furniture System
US20120245445A1 (en) * 2011-03-21 2012-09-27 Michael Darryl Black Glucose Monitoring System
PT2768942T (pt) * 2011-10-17 2020-01-21 Massachusetts Inst Technology Entrega intracelular
BR112014009713A2 (pt) * 2011-10-27 2017-04-18 Kimberly Clark Co administração transdérmica de agentes bioativos de alta viscosidade
KR101575039B1 (ko) 2012-07-19 2015-12-07 (주)아모레퍼시픽 노즐 장치 및 이를 포함하는 최소 침습형 주입 장치
BR112015005073B1 (pt) * 2012-09-13 2021-06-01 Amir Avraham Aplicador configurado para a administração de uma composição de melhoria de pele para uma pele e/ou subcútis de um sujeito, uso de um, microagulha e método para manufaturar uma microagulha
PL2897620T3 (pl) 2012-09-21 2020-11-02 Intensity Therapeutics, Inc Sposób leczenia nowotworu złośliwego
CN103157178B (zh) * 2013-02-05 2014-12-31 北京化工大学 精确控制微针插入长度的印章式工具
WO2014132239A1 (en) 2013-02-28 2014-09-04 Kimberly-Clark Worldwide, Inc. Drug delivery device
BR112015020328B1 (pt) 2013-02-28 2022-05-31 Sorrento Therapeutics, Inc Dispositivo de aplicação transdérmica de droga
CN105209104A (zh) 2013-05-23 2015-12-30 金伯利-克拉克环球有限公司 具有改进的开放通道横截面几何形状的微针
US10376674B2 (en) * 2014-09-15 2019-08-13 Ethicon, Inc. System and method for targeted delivery of therapeutic agents to tissue
PL3325081T3 (pl) * 2015-07-24 2021-12-20 Sorrento Therapeutics, Inc. Sposoby dostarczania limfatycznego środków czynnych
EP3925599A1 (en) * 2015-07-24 2021-12-22 Sorrento Therapeutics, Inc. Methods for better delivery of active agents to tumors

Also Published As

Publication number Publication date
JP7082041B2 (ja) 2022-06-07
RU2018104102A (ru) 2019-08-27
BR112018001292A2 (pt) 2018-09-11
EP3325080B1 (en) 2021-09-01
RU2719943C2 (ru) 2020-04-23
EP3325080A2 (en) 2018-05-30
CA2991455A1 (en) 2017-02-02
AU2021200146B2 (en) 2022-08-25
US20240238570A1 (en) 2024-07-18
US20210052871A1 (en) 2021-02-25
CN107921248A (zh) 2018-04-17
US10806913B2 (en) 2020-10-20
ES2891523T3 (es) 2022-01-28
DK3325080T3 (da) 2021-10-04
MX2022014277A (es) 2022-12-07
MX2018000166A (es) 2018-03-26
KR20180035209A (ko) 2018-04-05
EP3325080A4 (en) 2019-04-17
AU2021200146A1 (en) 2021-03-18
CN118902979A (zh) 2024-11-08
US20180193624A1 (en) 2018-07-12
HUE056410T2 (hu) 2022-02-28
RU2018104102A3 (pl) 2019-11-06
AU2022275397A1 (en) 2023-01-05
AU2016297823B2 (en) 2020-10-22
EP3925599A1 (en) 2021-12-22
JP2018521755A (ja) 2018-08-09
WO2017019526A2 (en) 2017-02-02
CA2991455C (en) 2023-10-10
AU2016297823A1 (en) 2018-02-15

Similar Documents

Publication Publication Date Title
CY2024035I2 (el) Συνθεσεις αντισωματων για τη θεραπεια ογκων
PL3325080T3 (pl) Sposoby lepszego dostarczania środków czynnych do guzów
IL264901B (en) Administration of kynurenine depleting enzymes for tumor therapy
SI3350157T1 (sl) Sestave za doziranje terapevtskih sredstev v celice
PL3377516T3 (pl) Kompozycja do leczenia nowotworu
HUE047477T2 (hu) Palbociclib szilárd dózisformái
ZA201506916B (en) Microstructure array for delivery of active agents
PL3283527T3 (pl) Leczenie skojarzone nowotworów
HRP20181679T1 (hr) Amidni spojevi za liječenje hiv
PL3297605T3 (pl) Kompozycje farmaceutyczne do stosowania miejscowego
DK3107563T3 (da) Glycomålrettede terapeutiske midler
DK3234107T3 (da) B-celler til in vivo-levering af terapeutiske midler
PL3310904T3 (pl) Komórkowy układ ukierunkowanego dostarczania substancji czynnej
LT2968221T (lt) S-ketamino hidrochlorido farmacinė kompozicija
LT2981255T (lt) Empagliflozino terapiniai panaudojimo būdai
KR102494289B9 (ko) 활성 혼합물
LT3116491T (lt) Terapiškai aktyvių junginių farmacinės kompozicijos
PL3186244T3 (pl) Analogi dioksolanowe urydyny w leczeniu raka
HRP20190101T1 (hr) Terapeutske uporabe empagliflozina
MA39483A (fr) Agents thérapeutiques cibles
SI4119569T1 (sl) Konjugirane protismiselne spojine za uporabo v terapiji
PL3325081T3 (pl) Sposoby dostarczania limfatycznego środków czynnych
IL256206A (en) Mct4 inhibitors for treating disease
DK3363428T3 (da) Perfusionsdoseringsform
HRP20181570T1 (hr) Režim doziranja spoja fgf-18